The Impella 2.5 L for percutaneous mechanical circulatory support in severe humoral allograft rejection

Heart transplant recipients who experience humoral rejection are at risk for hemodynamic instability. We report a case of a 64-year-old male with cardiogenic shock due to allograft rejection requiring mechanical support while undergoing intense immunosuppression. He underwent implantation of a micro...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of invasive cardiology Vol. 22; no. 3; pp. E37 - E39
Main Authors Beyer, Anna T, Hui, Peter Y, Hauesslein, Ernest
Format Journal Article
LanguageEnglish
Published United States 01.03.2010
Subjects
Biopsy
Graft Rejection - complications
Graft Rejection - immunology
Graft Rejection - therapy
Heart Transplantation - immunology
Heart Transplantation - physiology
Heart-Assist Devices
Humans
Immunity, Humoral - immunology
Immunoglobulins, Intravenous - therapeutic use
Male
Middle Aged
Myocardium - pathology
Plasmapheresis
Shock, Cardiogenic - etiology
Shock, Cardiogenic - therapy
Transplantation, Homologous
Treatment Outcome
Online AccessGet full text

Cover

More Information
Summary:Heart transplant recipients who experience humoral rejection are at risk for hemodynamic instability. We report a case of a 64-year-old male with cardiogenic shock due to allograft rejection requiring mechanical support while undergoing intense immunosuppression. He underwent implantation of a micro-axial endovascular pump (Impella). To our knowledge, this is the first reported case of successful Impella device deployment as a bridge-to-recovery strategy.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:1557-2501